Tuxarin Tablet, Extended Release
Product Images NDC 71269-040

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tuxarin (NDC 71269-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mainpointe Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tuxarin 01)

Chemical structure of the active ingredient in Tuxarin, showing a detailed molecular diagram with aromatic rings, an oxygen atom, and functional groups including a methoxy and hydroxyl group.*

FDA Label Image

Chemical Structure (Tuxarin 02)

Chemical structure diagram of the active ingredients codeine phosphate and chlorpheniramine maleate, showing their molecular arrangements with chlorine, nitrogen, and carboxyl groups as indicated.*

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

Label for Tuxarin ER tablets, extended-release, containing codeine phosphate 54.3 mg and chlorpheniramine maleate 8 mg per tablet. The label includes dosage instructions, storage conditions, and a warning to dispense with a medication guide. It is distributed by MainPointe Pharmaceuticals and contains 100 tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.